Vestor Capital’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,785
Closed -$54K 231
2022
Q2
$54K Hold
10,785
0.01% 185
2022
Q1
$77K Sell
10,785
-84
-0.8% -$695 0.01% 168
2021
Q4
$198K Sell
10,869
-8
-0.1% -$173 0.02% 120
2021
Q3
$213K Sell
10,877
-4,473
-29% -$170K 0.02% 113
2021
Q2
$688K Sell
15,350
-111
-0.7% -$5.14K 0.07% 86
2021
Q1
$777K Buy
15,461
+575
+4% +$39.2K 0.09% 82
2020
Q4
$1.33M Buy
+14,886
New +$1.25M 0.16% 69

Other funds holding CELL

Vestor Capital's CELL Position: Q3 2022 in Review

Vestor Capital sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 10,785 shares — an estimated $54K sold.

Vestor Capital first reported a position in CELL in Q4 2020 and held it in 7 quarters. The position peaked at $1.33M in Q4 2020. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

  • Vestor Capital reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Vestor Capital sold 10,785 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $54K.
  • Vestor Capital first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Vestor Capital's PhenomeX Inc. Common Stock position peaked at $1.33M in Q4 2020.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on Vestor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.